Description

Tesofensine Tablets

Tesofensine
CAS Number	1208070-53-4
Molar Mass	328.3 g.mol-1
Chemical Formula	C17H23Cl2NO
IUPAC Name	(1R,2R,3S)-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane

Introduction

Tesofensine Tablets represent a research compound known for its pharmacological properties, primarily explored in preclinical studies and scientific investigations. This product is intended solely for research purposes, and any mention of human consumption is strictly prohibited.

Key Characteristics

Tesofensine is characterized by its mechanism of action as a triple monoamine reuptake inhibitor, affecting the levels of serotonin, dopamine, and norepinephrine. This unique pharmacological profile has sparked interest in its potential applications across various research domains.

Research Applications

Researchers have turned their attention to Tesofensine Tablets for its applications in obesity treatment, mental health research related to addiction, and potential implications for type 2 diabetes. These investigations aim to uncover the compound’s effects on various physiological and psychological aspects.

Research Benefits

Tesofensine on Obesity Treatment

Scientific studies have explored the potential of Tesofensine in addressing obesity-related concerns. Investigations delve into its role as a weight-loss agent, seeking to understand the underlying mechanisms and efficacy in the treatment of obesity.

Tesofensine on Addiction (Mental Health Research)

Research in mental health has focused on Tesofensine’s impact on addiction-related behaviors. Studies aim to elucidate its potential as a therapeutic intervention for addiction, unraveling the neural pathways influenced by Tesofensine.

Tesofensine for Type 2 Diabetes

Scientific inquiry has explored the potential benefits of Tesofensine in the context of type 2 diabetes. Studies investigate its effects on glucose metabolism and insulin sensitivity, contributing valuable insights to diabetes research.

Summary

Tesofensine Tablets, designed exclusively for research purposes, have garnered attention for their potential in obesity treatment, mental health research related to addiction, and implications for type 2 diabetes. As researchers continue to delve into its applications, Tesofensine remains a subject of scientific interest and investigation.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Son JW, Kim S. Comprehensive Review of Current and Upcoming Anti-Obesity Drugs. Diabetes Metab J. 2020;44(6):802-818. [Read More].
2. Samet Kose & Mesut Cetin (2018) Triple reuptake inhibitors (TRIs): do they promise us a rose garden? Psychiatry and Clinical Psychopharmacology, 28:2, 119-122, DOI: 10.1080/24750573.2018.1443386. [Read More].